Advice for Management of Clinical trials in relation to Coronavirus

UK – Exceptional use of non-UKCA marked medical devices

A manufacturer can apply to supply a medical device that does not comply with the law to protect a patient’s health if there is...
SCCS - Final Opinion on Solubility of Synthetic Amorphous Silica (SAS)

Europe – UPDATE – MDCG 2020-3 Rev.1 – Guidance on significant changes regarding the...

Article 120(3) of the Medical Device Regulation (EU) 2017/745 (MDR), last amended by Regulation (EU) 2023/607, states that devices which continue to comply with...

Europe – Guidance on the procedural aspects for the consultation to the European Medicines...

This guidance document is intended to provide the relevant parties, in particular notified bodies, device manufacturers and medicinal product applicants, with information about procedural...

UK – New device launched for diagnosing prostate cancer

CamPROBE may save vital time and money while reducing the risk of infection November will witness the launch of a new device that is set...
SCCS - Final Opinion on Solubility of Synthetic Amorphous Silica (SAS)

Europe – Update – MDCG 2020-16 Rev.2 – Guidance on Classification Rules for in...

This guidance, relating to the application of Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR) addresses the classification of in vitro diagnostic...

Europe – Questions & Answers for applicants, marketing authorisation holders of medicinal products and...

This Question and Answer (Q&A) document provides practical considerations concerning the implementation of the medical devices and the in vitro diagnostic medical devices regulations. This...
As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – IVDR Watch: European regulators add ISO 14971 to harmonized standards list

European regulators just updated the harmonized standards list for the In-Vitro Diagnostic Medical Devices Regulation (IVDR) days ahead of its implementation date on May...
Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

Europe – MDCG 2022-14 – Transition to the MDR and IVDR – Notified body...

The MDCG recognises that significant and urgent challenges remain in ensuring sufficient capacity of notified bodies and readiness of manufacturers in order to allow medical...

Europe – MDCG 2022-18 : Position Paper on the application of Article 97 MDR...

In accordance with Article 5 of Regulation (EU) 2017/745 on medical devices (MDR), a device may be placed on the market only if it complies...
As coronavirus roils region, EU device body adamant about steps to hit MDR deadline

Europe – Le règlement (UE) 2023/607

Le règlement (UE) 2023/607, publié au JOUE, modifie les dispositions transitoires relatives à certains dispositifs médicaux et à certains dispositifs médicaux de diagnostic in...

NOS PROCHAINES FORMATIONS